|
|
Volumn 5, Issue 1, 2005, Pages 16-19
|
|
Adjusting therapeutic dosage regimens to optimise the balance of benefit to harm
a,b
|
|
Author keywords
Benefit to harm balance; Dosage regimens; Monitoring drug therapy
|
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMIODARONE;
ANASTROZOLE;
AZATHIOPRINE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBIMAZOLE;
CEFALEXIN;
CLOMETHIAZOLE;
CYCLOSPORIN;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUCOCORTICOID;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LITHIUM;
METFORMIN;
MORPHINE;
NEUROLEPTIC AGENT;
OPIATE;
PHENYTOIN;
PROPRANOLOL;
TAMOXIFEN;
THIAZIDE DIURETIC AGENT;
THYROXINE;
WARFARIN;
AGE;
BREAST CANCER;
DECISION MAKING;
DIABETES MELLITUS;
DISTRIBUTION VOLUME;
DOSE CALCULATION;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG CHOICE;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG DISPOSITION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
DRUG SAFETY;
DYSKINESIA;
ELECTROLYTE DISTURBANCE;
ENDOMETRIUM CANCER;
HUMAN;
HYPERTENSION;
KIDNEY FAILURE;
LIVER DISEASE;
PATIENT MONITORING;
REMISSION;
REVIEW;
TACHYPHYLAXIS;
THROMBOEMBOLISM;
THYROTOXICOSIS;
VEIN THROMBOSIS;
|
|
EID: 14644406859
PISSN: 14702118
EISSN: None
Source Type: Journal
DOI: 10.7861/clinmedicine.5-1-16 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
